IDH2 mutation associated with favourable outcome in older adults with newly diagnosed ALL treated with lower-intensity therapy

Demographics, characteristics, survival and outcomes in older, untreated, AML with NPM1 mutations or KMT2A rearrangements

Beat AML master trial update: A clinical trial for acute myeloid leukaemia

Impact of MRD on progression-free survival in MM patients treated with isatuximab, lenalidomide, bortezomib and dexamethasone

IRANCANSURV: Dissecting the variances in childhood cancer survival across Iran

30 minute infusion of isatuximab shows potential in newly diagnosed multiple myeloma

Understanding cognitive impairment for elderly patients undergoing CAR T therapy

SIOG 2024: Updates in haematology

Expectations and priorities of older patients with cancer: the PRIORITY multicenter cohort study

Isa-VRd shows greater efficacy compared to VRd in transplant-ineligible NDMM patients

Daratumumab-based maintenance regimens show favourable responses in transplant-eligible NDMM

Optimising benefit-risk and minimising impact on quality of life with BCMA-targeting agents in an outpatient setting